Sanara MedTech Inc. 8K

Sanara MedTech Inc. agreed to be acquired by MiMedx Group, Inc. in a cash-and-stock merger where each Sanara share will be converted into $33.00 in cash plus 0.4735 shares of MiMedx common stock, subject to stockholder approval and customary closing conditions.

On July 29, 2026, Sanara MedTech Inc. entered into an Agreement and Plan of Merger with MiMedx Group, Inc. and Mustang Merger Sub, Inc., under which Mustang Merger Sub will merge with and into Sanara MedTech, with Sanara continuing as the surviving corporation and becoming a wholly owned subsidiary of MiMedx. Each outstanding share of Sanara common stock (other than treasury, affiliate-held, and properly perfected dissenting shares) will be converted at the effective time into the right to receive $33.00 in cash plus 0.4735 shares of MiMedx common stock, subject to cash-in-lieu payments for fractional MiMedx shares. Sanara’s board of directors has unanimously determined that the merger is advisable, fair, and in the best interests of Sanara and its stockholders, approved the transaction, recommended that stockholders adopt the merger agreement, and certain stockholders have executed voting and support agreements in favor of the merger. The agreement also provides for the treatment of Sanara equity awards, which will be canceled and converted into cash and stock consideration as specified, and sets forth customary representations, covenants, conditions to closing, termination provisions, and a structure for financing and regulatory approvals necessary to complete the transaction.

Filing Facts

CIK

714256

Ticker

-

Form

8K

Source Type

sec

Accession

0001493152-26-035196

Alert Tier

8